Yutaro Kubota
Tokyo, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 128 publications
Long-Term Survival Outcomes of Modified-FOLFOXIRI Plus Cetuximab Versus Bevacizumab in RAS/BRAF Wild-Type Metastatic Colorectal Cancer: Final Analysis of the DEEPER Trial.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: August 27, 2026
Correction: Tumor Akkermansia muciniphila predicts clinical response to immune checkpoint inhibitors in non-small-cell lung cancer patients with low PD-L1 expression.
Journal: Frontiers in immunology
Published: March 10, 2026
Elevated plasma IgG is associated with improved treatment response and survival in advanced non‑small cell lung cancer patients treated with anti‑PD‑1 therapy.
Journal: Scientific reports
Published: February 05, 2026
Association of Intratumoral Macrophage Subsets with Treatment Outcomes in Patients with Stage IV Solid Tumors.
Journal: Laboratory investigation; a journal of technical methods and pathology
Published: February 05, 2026
Polymorphisms of FGFR Pathway-related Factors and Capecitabine-induced Hand-foot Syndrome in Japanese Patients With Colorectal Cancer.
Journal: Anticancer research
Published: November 20, 2025
Methionine Restriction Alone Induces T-cell-mediated Immunotherapy of Osteosarcoma in a Syngeneic Mouse Model.
Journal: In vivo (Athens, Greece)
Published: November 12, 2025
Efficacy and safety of necitumumab and pembrolizumab combination therapy in advanced non-small-cell lung cancer with ≥50% PD-L1 expression: A nonrandomized phase II trial.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: October 31, 2025
Increased alanine aminotransferase level as a predictive marker of hand-foot syndrome in patients receiving capecitabine: A retrospective cohort study.
Journal: Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners
Published: October 24, 2025
Association of IL12RB2, RORC, and class II HLA polymorphisms with severe erythema multiforme of regorafenib in Japanese patients with colorectal cancer.
Journal: Cancer chemotherapy and pharmacology
Published: June 11, 2025
Vinegar intake in patients undergoing immune checkpoint inhibitor therapy: food frequency questionnaire study.
Journal: Frontiers in immunology
Published: June 03, 2025
Last Updated: 09/26/2026